About
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
- Headquarters
- Industries
- Employees201-500
Photos
Add photos to showcase Geron’s culture
Values
Add Geron’s values
Insider experiences
Share your experience of working at Geron
Org chart
View org chartJohn A. Scarlett
Chairman, President & CEO
Collapse
Andrew J. Grethlein
EVP & COO
Edward Koval
EVP & Chief Business Officer
Aleksandra Rizo
EVP, Chief Medical Officer
Anil Kapur
EVP, Corporate Strategy & Chief Commercial Officer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Olivia K. Bloom
EVP, Finance, CFO & Treasurer
Stephen N. Rosenfield
EVP, General Counsel & Corporate Secretary
Teams
View all (0)Add your teams to show how people work together at Geron
Jobs
View all (0)Add jobs to your org chart to show candidates who they’ll work with
Wires
View all (0)Publish company announcements to get more exposure
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.